Vogel WV - Search Results

1

Quantification of biochemical PSA dynamics after radioligand therapy with [¹⁷⁷Lu]Lu-PSMA-I&T using a population pharmacokinetic/pharmacodynamic model.

Siebinga H, de Wit-van der Veen BJ, de Vries-Huizing DMV, Vogel WV, Hendrikx JJMA, Huitema ADR. Siebinga H, et al. Among authors: vogel wv. EJNMMI Phys. 2024 Apr 24;11(1):39. doi: 10.1186/s40658-024-00642-2. EJNMMI Phys. 2024. PMID: 38656678 Free PMC article.

2

Muscarinic inhibition of salivary glands with glycopyrronium bromide does not reduce the uptake of PSMA-ligands or radioiodine.

Mohan V, Bruin NM, Tesselaar MET, de Boer JP, Vegt E, Hendrikx JJMA, Al-Mamgani A, van de Kamer JB, Sonke JJ, Vogel WV. Mohan V, et al. Among authors: vogel wv. EJNMMI Res. 2021 Mar 12;11(1):25. doi: 10.1186/s13550-021-00770-1. EJNMMI Res. 2021. PMID: 33710423 Free PMC article.

3

Tolerability of concurrent external beam radiotherapy and [¹⁷⁷Lu]Lu-PSMA-617 for node-positive prostate cancer in treatment naïve patients, phase I study (PROQURE-I trial).

van der Sar ECA, Braat AJAT, van der Voort-van Zyp JRN, van der Veen BS, van Leeuwen PJ, de Vries-Huizing DMV, Hendrikx JMA, Lam MGEH, Vogel WV. van der Sar ECA, et al. Among authors: vogel wv. BMC Cancer. 2023 Mar 23;23(1):268. doi: 10.1186/s12885-023-10725-5. BMC Cancer. 2023. PMID: 36959540 Free PMC article. Clinical Trial.

4

Preclinical imaging characteristics and quantification of Platinum-195m SPECT.

Aalbersberg EA, de Wit-van der Veen BJ, Zwaagstra O, Codée-van der Schilden K, Vegt E, Vogel WV. Aalbersberg EA, et al. Among authors: vogel wv. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1347-1354. doi: 10.1007/s00259-017-3643-2. Epub 2017 Feb 11. Eur J Nucl Med Mol Imaging. 2017. PMID: 28190123

5

Lack of tumor uptake of 131-I labeled rituximab in a patient with a CD20 positive lymphoma lesion.

Tran L, Huitema AD, Vogel WV, Beijnen JH, Baars JW. Tran L, et al. Among authors: vogel wv. J Oncol Pharm Pract. 2012 Dec;18(4):417-20. doi: 10.1177/1078155211428998. Epub 2012 Jan 6. J Oncol Pharm Pract. 2012. PMID: 22228555

6

CD20 antigen imaging with ¹²⁴I-rituximab PET/CT in patients with rheumatoid arthritis.

Tran L, Huitema AD, van Rijswijk MH, Dinant HJ, Baars JW, Beijnen JH, Vogel WV. Tran L, et al. Among authors: vogel wv. Hum Antibodies. 2011;20(1-2):29-35. doi: 10.3233/hab20110239. Hum Antibodies. 2011. PMID: 21558621

7

The pharmacokinetics of ¹²⁴I-rituximab in patients with rheumatoid arthritis.

Tran L, Vogel WV, Sinaasappel M, Muller S, Baars JW, van Rijswijk M, Dinant HJ, Beijnen JH, Huitema AD. Tran L, et al. Among authors: vogel wv. Hum Antibodies. 2011;20(1-2):7-14. doi: 10.3233/hab20110237. Hum Antibodies. 2011. PMID: 21558619

8

The effect of eating on the uptake of PSMA ligands in the salivary glands.

Mohan V, Bruin NM, van de Kamer JB, Sonke JJ, Vogel WV. Mohan V, et al. Among authors: vogel wv. EJNMMI Res. 2021 Sep 26;11(1):95. doi: 10.1186/s13550-021-00838-y. EJNMMI Res. 2021. PMID: 34568982 Free PMC article.

9

Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study.

Donswijk ML, Wondergem M, de Wit-van der Veen L, Bruin NM, van Leeuwen PJ, van der Poel HG, Stokkel MPM, Vogel WV. Donswijk ML, et al. Among authors: vogel wv. EJNMMI Res. 2022 Jul 27;12(1):42. doi: 10.1186/s13550-022-00913-y. EJNMMI Res. 2022. PMID: 35895129 Free PMC article.

10

Clinical evaluation of respiration-induced attenuation uncertainties in pulmonary 3D PET/CT.

Kruis MF, van de Kamer JB, Vogel WV, Belderbos JS, Sonke JJ, van Herk M. Kruis MF, et al. Among authors: vogel wv. EJNMMI Phys. 2015 Dec;2(1):4. doi: 10.1186/s40658-014-0107-7. Epub 2015 Feb 24. EJNMMI Phys. 2015. PMID: 26501806 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

166 results

Search Page